Axel M. Gressner

26.8k citations

303 papers · 14.7k indexed · 3 hit papers · h-index 62

Impact in

Hepatology top 0.05%
- Liver physiology and pathology
- Liver Disease and Transplantation
Epidemiology top 0.2%
- Liver Disease Diagnosis and Treatment

Papers in

Hepatology 147
- Liver physiology and pathology 132
Cell Biology 54
- Proteoglycans and glycosaminoglycans research 44

Co-authors: Ralf Weiskirchen Ursula Meier O Gressner Max G. Bachem Birgit Lahme Ira G. Wool Steven Dooley D. Meyer
Journals: Clinical Chemistry and Laboratory Medicine (CCLM) (27 papers)Hepatology (22 papers)Biochemical and Biophysical Research Communications (21 papers)Journal of Hepatology (20 papers)Clinica Chimica Acta (18 papers)
Partner nations: Germany United States China

In The Last Decade

Axel M. Gressner

297 papers receiving 14.3k citations

Hit Papers

align trajectories log scale

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF‐β as major players and therapeutic targets 2006 · 624 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Journal of Cellular and Molecular Medicine
2004 Clinical Chemistry
2002 Frontiers in bioscience

Peers

Countries citing papers authored by Axel M. Gressner

Since Specialization

Citations

This map shows the geographic impact of Axel M. Gressner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel M. Gressner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel M. Gressner more than expected).

Fields of papers citing papers by Axel M. Gressner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel M. Gressner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel M. Gressner. The network helps show where Axel M. Gressner may publish in the future.

Co-authors

The 25 scholars most cited alongside Axel M. Gressner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Axel M. Gressner Line = papers co-authored together Axel M. Gressner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Inverse association between serum concentrations of actin-free vitamin D-binding protein and the histopathological extent of fibrogenic liver disease or hepatocellular carcinoma European Journal of Gastroenterology & Hepatology ·O Gressner, Chunfang Gao, Monika Siluschek, Philipp Kim, Axel M. Gressner	2009	20
2	Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® GI Monitor assay on the UniCel® DxI 800 Immunoassay System Clinical Chemistry and Laboratory Medicine (CCLM) ·P Stieber, Rafael Molina, Massimo Gion, Axel M. Gressner, Frédéric Troalen, Stefan Holdenrieder, José Maria Augé, Matelda Zancan, Matthias Wycislo, Véronique Jarrige	2008	16
3	Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells Differentiation ·W Wirz, Marianne Antoine, Carmen G. Tag, Axel M. Gressner, Thomas Korff, Claus Hellerbrand, Paul Kiefer	2008	61
4	Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre‐disposition pending between fiction and reality Journal of Cellular and Molecular Medicine ·O Gressner, Ralf Weiskirchen, Axel M. Gressner	2007	80
5	Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH—an in vitro study Nephrology Dialysis Transplantation ·J. Unger, C. Haltern, Britta Portz, B. Dohmen, Axel M. Gressner, Rolf Rossaint	2006	14
6	Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis Laboratory Investigation ·Erawan Borkham‐Kamphorst, Jens Herrmann, Doris Stoll, Jens Treptau, Axel M. Gressner, Ralf Weiskirchen	2004	126
7	Induction of cell death in activated hepatic stellate cells by targeted gene expression of the thymidine kinase/ganciclovir system Biochemical and Biophysical Research Communications ·Nora Janoschek, Eddy Van de Leur, Axel M. Gressner, Ralf Weiskirchen	2004	11
8	Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis Biochemical and Biophysical Research Communications ·Erawan Borkham‐Kamphorst, Doris Stoll, Axel M. Gressner, Ralf Weiskirchen	2004	76
9	Comparative analysis of adenoviral transgene delivery via tail or portal vein into rat liver Archives of Virology ·Jens Herrmann, Bärbel Abriss, Eddy Van de Leur, Sabine Weiskirchen, Axel M. Gressner, Ralf Weiskirchen	2004	21
10	Standardized flow cytometric method for the accurate determination of platelet counts in patients with severe thrombocytopenia Cytometry ·Dagmar Kunz, H.-G. H�ffkes, Wolfram S. Kunz, Axel M. Gressner	2000	10
11	Function and metabolism of collagen and other extracellular matrix proteins RWTH Publications (RWTH Aachen) ·Detlef Schuppan, Axel M. Gressner	1999	12
12	Gene expression of syndecans and betaglycan in isolated rat liver cells Cell and Tissue Research ·Olaf H. Weiner, Martin Zoremba, Axel M. Gressner	1996	27
13	Variation of immunocytochemical expression of transforming growth factor (TGF)-β in hepatocytes in culture and liver slices Cell and Tissue Research ·Axel M. Gressner, Ulrich Wulbrand	1996	20
14	Transforming growth factor β (TGF-β) expression in isolated and cultured rat hepatocytes Journal of Cellular Physiology ·Chunfang Gao, Gabriele Gressner, Martin Zoremba, Axel M. Gressner	1996	51
15	Perisinusoidal lipocytes and fibrogenesis. Gut ·Axel M. Gressner	1994	49
16	Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. Journal of Clinical Investigation ·Max G. Bachem, D. Meyer, Ralph Melchior, Klaus-Martin Sell, Axel M. Gressner	1992	205
17	An evaluation of a monoclonal antibody based sandwich radioimmunoassay for the col 1 3 amino terminal propeptide of type iii procollagen in serum Clinical Chemistry ·Axel M. Gressner	1990	2
18	Transforming growth factors (TGFα and TGFβH) stimulate chondroitin sulfate and hyaluronate synthesis in cultured rat liver fat storing cells FEBS Letters ·Max G. Bachem, Uwe Riess, Ralph Melchior, Klaus-Martin Sell, Axel M. Gressner	1989	52
19	Inflammation-induced synthesis of proteoheparan sulfate: A novel acute-phase reactant in rat hepatocytes Inflammation ·Assadollah Djovkar, Axel M. Gressner	1987	1
20	Synthesis in Vitro of Glycosaminoglycans in Regenerating Rat Liver Clinical Chemistry and Laboratory Medicine (CCLM) ·Axel M. Gressner, J. E. Cadenbach, H. Greiling	1981	2

About Axel M. Gressner

Axel M. Gressner is a scholar working on Hepatology, Cell Biology, Epidemiology, Immunology and Allergy and Molecular Biology, having authored 303 papers that have together received 14.7k indexed citations. Recurring topics across this work include Liver physiology and pathology (132 papers), Liver Disease Diagnosis and Treatment (65 papers), TGF-β signaling in diseases (50 papers), Proteoglycans and glycosaminoglycans research (44 papers), Glycosylation and Glycoproteins Research (30 papers), Pancreatic function and diabetes (25 papers), Fibroblast Growth Factor Research (24 papers) and Pancreatic and Hepatic Oncology Research (23 papers). The work is most often cited by research in Hepatology (6.9k citations), Epidemiology (5.6k citations), Pharmacology (711 citations), Cell Biology (1.3k citations) and Molecular Biology (5.2k citations). Axel M. Gressner has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Ralf Weiskirchen, Ursula Meier, O Gressner, Max G. Bachem, Birgit Lahme, Ira G. Wool, Steven Dooley, D. Meyer, K. Mangasser-Stephan and Eray Yagmur. Their work appears in journals such as Clinical Chemistry and Laboratory Medicine (CCLM), Hepatology, Biochemical and Biophysical Research Communications, Journal of Hepatology and Clinica Chimica Acta.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact